# Cardio-protective Effect of Metformin in Patients Undergoing PCI

> **NCT05708053** · PHASE3 · UNKNOWN · sponsor: **Future University in Egypt** · enrollment: 80 (estimated)

## Conditions studied

- Elective Percutaneous Coronary Intervention
- Ischemic Reperfusion Injury

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05708053
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-09
- **Primary completion:** 2021-12-09
- **Final completion:** 2024-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708053, "Cardio-protective Effect of Metformin in Patients Undergoing PCI". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05708053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*